Basic Information
Basic information for NKILA-202-86aa
Peptide Name NKILA-202-86aa
Genome Position chr20:57711409-57711666[+]
Species Human
Peptide Sequence MLPELSQKDQEACSGEVKPRDVAQAGPSSLEESKRAQPRGRFRGTDRLLFGRRSSLLEPQPALGQDPGPGPGVGQYPASTPDGTLL
Peptide Length 86
Unique Yes
Grand Average of Hydropathicity -0.8267
Relative Molecular Mass 10673.53
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000278709;NKILA
Transcript ID/Name ENST00000614771;NKILA-202
Transcript Length 2625
Coding Ability 0.4392
DNA Sequence Corresponding to Peptide ATGCTGCCAGAGCTCTCCCAGAAAGACCAGGAGGCTTGTTCTGGAGAAGTCAAGCCCAGGGATGTGGCTCAGGCTGGTCCAAGCTCTTTGGAGGAGTCCAAGCGTGCCCAGCCCAGAGGGAGGTTCAGAGGCACTGACCGTCTTCTGTTTGGGAGGAGAAGCTCACTCTTGGAGCCACAGCCAGCACTAGGTCAGGACCCAGGCCCCGGCCCAGGAGTGGGGCAATACCCAGCGTCTACCCCAGATGGCACCCTGCTG
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :